Massachusetts Financial Services’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-61,878
Closed -$640K 826
2023
Q1
$640K Sell
61,878
-1,752
-3% -$22.4K ﹤0.01% 794
2022
Q4
$876K Buy
63,630
+1,347
+2% +$18.7K ﹤0.01% 786
2022
Q3
$1.27M Sell
62,283
-9,859
-14% -$216K ﹤0.01% 767
2022
Q2
$1.4M Sell
72,142
-8,345
-10% -$171K ﹤0.01% 755
2022
Q1
$1.73M Buy
80,487
+826
+1% +$18.7K ﹤0.01% 762
2021
Q4
$2.2M Sell
79,661
-1,613
-2% -$44.5K ﹤0.01% 769
2021
Q3
$2.11M Sell
81,274
-1,066
-1% -$28.5K ﹤0.01% 780
2021
Q2
$2.23M Buy
82,340
+707
+0.9% +$17.3K ﹤0.01% 766
2021
Q1
$1.91M Sell
81,633
-9,675
-11% -$196K ﹤0.01% 775
2020
Q4
$1.4M Buy
91,308
+23,994
+36% +$304K ﹤0.01% 773
2020
Q3
$812K Sell
67,314
-43,261
-39% -$411K ﹤0.01% 793
2020
Q2
$1.13M Sell
110,575
-2,820
-2% -$29.1K ﹤0.01% 731
2020
Q1
$1.18M Buy
113,395
+17,947
+19% +$225K ﹤0.01% 726
2019
Q4
$1.53M Sell
95,448
-10,300
-10% -$157K ﹤0.01% 738
2019
Q3
$1.95M Buy
105,748
+11,796
+13% +$231K ﹤0.01% 722
2019
Q2
$1.85M Buy
93,952
+13,090
+16% +$267K ﹤0.01% 740
2019
Q1
$1.85M Buy
80,862
+2,990
+4% +$64.9K ﹤0.01% 726
2018
Q4
$1.57M Buy
77,872
+6,061
+8% +$125K ﹤0.01% 727
2018
Q3
$1.56M Sell
71,811
-168
-0.2% -$3.73K ﹤0.01% 745
2018
Q2
$1.6M Buy
71,979
+9,860
+16% +$202K ﹤0.01% 731
2018
Q1
$1.07M Buy
62,119
+2,160
+4% +$36K ﹤0.01% 753
2017
Q4
$997K Buy
59,959
+45,201
+306% +$771K ﹤0.01% 769
2017
Q3
$252K Buy
+14,758
New +$248K ﹤0.01% 826
2015
Q2
Sell
-32,355
Closed -$576K 883
2015
Q1
$576K Sell
32,355
-2,332
-7% -$43.3K ﹤0.01% 833
2014
Q4
$659K Sell
34,687
-1,616
-4% -$27.4K ﹤0.01% 829
2014
Q3
$498K Sell
36,303
-1,000
-3% -$14.3K ﹤0.01% 841
2014
Q2
$609K Buy
+37,303
New +$540K ﹤0.01% 837

Other funds holding ANGO

Massachusetts Financial Services's ANGO Position: Q2 2023 in Review

Massachusetts Financial Services sold out of AngioDynamics (ANGO) in Q2 2023, closing a stake of 61,878 shares — an estimated $640K sold.

Massachusetts Financial Services first reported a position in ANGO in Q2 2014 and held it in 27 quarters. The position peaked at $2.23M in Q2 2021. 156 funds tracked by Wall St. Rank hold ANGO as of Q2 2023.

  • Massachusetts Financial Services reported no remaining AngioDynamics position as of Q2 2023 after selling out during the quarter.
  • Massachusetts Financial Services sold 61,878 AngioDynamics shares in Q2 2023, an estimated $640K.
  • Massachusetts Financial Services first reported a position in AngioDynamics in Q2 2014 and held it in 27 quarters.
  • Massachusetts Financial Services's AngioDynamics position peaked at $2.23M in Q2 2021.
  • 156 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2023.

Based on Massachusetts Financial Services's 13F filing for Q2 2023, filed 9 Aug 2023.